Dai Han Pharm Co Ltd (023910)

Currency in KRW
28,950
0(0.00%)
Closed·
023910 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
28,80029,200
52 wk Range
26,00033,950
Key Statistics
Bid/Ask
28,900.00 / 28,950.00
Prev. Close
28,950
Open
29,100
Day's Range
28,800-29,200
52 wk Range
26,000-33,950
Volume
16.98K
Average Volume (3m)
15.84K
1-Year Change
10.0952%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
023910 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
40,000
Upside
+38.17%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 4 consecutive years

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Daihan Pharmaceutical Co.,Ltd. engages in the manufacture and sale of therapeutic drugs in South Korea. The company offers various drugs, such as prescription, OTC, and quasi drugs, as well as offers various infusion related solutions. Daihan Pharmaceutical Co.,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea.

Employees
553

Compare 023910 to Peers and Sector

Metrics to compare
023910
Peers
Sector
Relationship
P/E Ratio
6.2x7.0x−0.4x
PEG Ratio
-0.110.00
Price/Book
0.6x0.9x2.6x
Price / LTM Sales
0.8x0.7x3.1x
Upside (Analyst Target)
38.2%43.9%47.4%
Fair Value Upside
Unlock9.1%7.0%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 40,000
(+38.17% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -
Dividend Yield
3.45%
Industry Median 0.93%
Annualised payout
1,000.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
18-03-2026
EPS / Forecast
-- / --
Revenue / Forecast
51.1B / 53.5B
EPS Revisions
Last 90 days

023910 Income Statement

FAQ

What Is the Dai Han Pharm (023910) Share Price Today?

The Dai Han Pharm share price today is 28,950 KRW.

What is the current Dai Han Pharm (023910) share price and day range?

As of 27-04-2026, the Dai Han Pharm share price is 28,950 KRW, with a previous close of 28,950 KRW. The share price has ranged from 28,800 to 29,200 KRW today, while the 52-week range spans from 26,000 to 33,950 KRW.

What Is the Dai Han Pharm Market Cap?

As of today, Dai Han Pharm market cap is 170.23B.

Does Dai Han Pharm Pay Dividends? What's The Current Dividend Yield?

The Dai Han Pharm dividend yield is 3.45%.

What Is the Dai Han Pharm (023910) Share Price Target?

The average 12-month share price target for Dai Han Pharm is 40,000 KRW, with a high estimate of 40000 KRW and a low estimate of 40000 KRW. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +38.17% Upside potential.

When Is the Next Dai Han Pharm Earnings Date?

Dai Han Pharm will release its next earnings report on 18-05-2026.

From a Technical Analysis Perspective, Is 023910 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

What Stock Exchange Does Dai Han Pharm Trade On?

Dai Han Pharm is listed and trades on the KOSDAQ.

What Is the Stock Symbol for Dai Han Pharm?

The stock symbol for Dai Han Pharm is "023910."

How Many Times Has Dai Han Pharm Stock Split?

Dai Han Pharm has split 1 times.

How Many Employees Does Dai Han Pharm Have?

Dai Han Pharm has 553 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.